Thanks in part to our petition and your support, Marinus Pharmaceuticals confirmed that they are working to provide Ganaxalone to any trial participant that responded well to the medicine. They are creating an expanded access program in different countries around the world for these patients.

Thank you again for your support. It means reduced seizures and better quality of life for TSC patients with epilepsy around the world. In a word, it means hope. 

If you were a trial participant and need more information, please visit https://marinuspharma.com/contact-us/ or email the following inboxes:

MedInfo@marinuspharma.com

Info@marinuspharma.com

Sincerely, 

John Musselman